EpiCor postbiotic – Immune health in children

Recent research underscores the significant role of postbiotics in enhancing immune health, particularly in children. This study involves 256 children aged 4 to 12 evaluated the effects of daily supplementation with 500 mg of EpiCor postbiotic over 84 days. The findings revealed that children receiving EpiCor experienced a statistically significant reduction in cold and flu symptom severity compared to the placebo group. Specifically, there was a notable decrease in symptoms such as sore throat and muscle aches. Additionally, those supplemented with EpiCor were 1.73 times less likely to require cold and flu medications, indicating a meaningful benefit in managing common illnesses.These results highlight the potential of EpiCor postbiotic as an effective supplement to support immune health in children, offering a promising avenue for reducing the impact of common respiratory infections.

Source: https://www.nature.com/articles/s41390-024-03331-z